IBXXF.US Imagion Biosystems Limited

Healthcare Biotechnology USA Stocks
0.0040 USD
Close of Nov 15, 2026
0.0040 0.0300
Market cap
USD 3.21M
P/E
-
P/B
5.46x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is IBXXF.US undervalued?

Graham number

The Graham number of Imagion Biosystems Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Imagion Biosystems Limited fundamental analysis

No fundamental analysis for Imagion Biosystems Limited yet.

Imagion Biosystems Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Imagion Biosystems Limited

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also dev…

Full company profile